Zoono at Cutting Edge of Reducing Risk of African Swine Flu Outbreaks

Paul Hislop, CEO and majority shareholder of ASX listed ZOONO Group Ltd (ZNO) confirmed at their AGM held in Sydney on 7th November 2109 that Zoono was at that cutting edge of...

Perth Biotech Increases Sanitiser Shipment Amid Virus Outbreak

Merlin Chew of The West Australian Monday, 10 February 2020 2:30PM Holista Colltech chief executive Dr Rajen M with the NatShield Sanitizer. Credit: Supplied

First COVID-19 vaccine found to be safe, able to generate rapid immune response in...

Reviewed by Emily Henderson, B.Sc.May 22 2020 The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans,...

Creso Pharma’s Technological Breakthrough Set To Expand Human Health Cannabis Product Line

By BioChannel -   February 10th 2020  566  By Jonathan Jackson Creso Pharma Limited (ASX:CPH), the ASX-listed, Swiss-based innovative medical cannabis product developer, has started 2020 strongly as...

VarmX bags €32m in Series B round – European Biotechnology News

Leiden-based coagulant developer VarmX NV has closed a €32m Series B financing to push the Phase II development of VMX-C001, a venom-based modified recombinant Factor X. New investors LSP, Ysios Capital, INKEF Capital and Lundbeckfonden...

Polycistronic delivery of IL-10 and NT-3 to enhance spinal cord injury repair

Reviewed by Emily Henderson, B.Sc.Apr 18 2020 Spinal cord injury (SCI) creates a complex microenvironment that is not conducive to repair; growth factors are in short supply, whereas factors that inhibit regeneration are plentiful. In...

Stay connected

50,943FollowersFollow
14,700SubscribersSubscribe

Recent posts

Random article